glp-1 and kidney Potential renoprotective effects of GLP1 receptor agonists. The GLP-1 drugs may extend life,

This blog post takes a deep dive into what this means for patients, separating fact from fear, and helping you understand how to balance the benefits and risks of GLP-1 therapy

On one side, evidence from randomized controlled trials suggests that circulating levels of carnitine may increase the risk of atherosclerosis and CVD

This article aims to take you on an enlightening journey of knowing when you have low levels of glutathione

[24] In another human clinical trial conducted on a sample of pulmonary tuberculosis patients, epitalon did not appear to correct pre-existing structural aberrations of chromosomes associated with telomere degradation, but did appear to exert a protective effect against the future development of additional chromosomal aberrations